A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : GK / ginkgolide K

[Related PubMed/MEDLINE]
Total Number of Papers: 18
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   GK  (>> Co-occurring Abbreviation)
Long Form:   ginkgolide K
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-kappaB pathway in rats. AA, ADP, ELISA, GA, GB, GDL, IL-1beta, LDH, LPS, MCAO/R, NF-kappaB, OGD/R, PAF, TLR4, TNF-alpha
2019 Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo. BB, EGb, GA, GB, HO-1, IHC, MCAO, Nrf2, OGD, p-Akt, p-Nrf2, SOD
2019 Ginkgolide K supports remyelination via induction of astrocytic IGF/PI3K/Nrf2 axis. CPZ, MS
2019 The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review. GA, GB, GC, GJ, GL, GM, rt-PA
2019 The therapeutic potential of ginkgolide K in experimental autoimmune encephalomyelitis via peripheral immunomodulation. Th17
2018 Comparing the role of Ginkgolide B and Ginkgolide K on cultured astrocytes exposed to oxygen‑glucose deprivation. CNS, GB, IL, OGD, PAF
2018 Ginkgolide K promotes angiogenesis in a middle cerebral artery occlusion mouse model via activating JAK2/STAT3 pathway. tMCAO
2018 Ginkgolide K promotes astrocyte proliferation and migration after oxygen-glucose deprivation via inducing protective autophagy through the AMPK/mTOR/ULK1 signaling pathway. AMPK, CC, EdU, LC3, mTOR, OGD
2018 Ginkgolide K promotes the clearance of A53T mutation alpha-synuclein in SH-SY5Y cells. alpha-syn, GB, PD
10  2018 Ginkgolide K protects SH‑SY5Y cells against oxygen‑glucose deprivation‑induced injury by inhibiting the p38 and JNK signaling pathways. MAPKs, OGD, ROS
11  2017 Ginkgolide K attenuates neuronal injury after ischemic stroke by inhibiting mitochondrial fission and GSK-3beta-dependent increases in mitochondrial membrane permeability. ANT, CypD, mPTP, OGD/R
12  2017 Pharmacokinetics of the prototype and hydrolyzed carboxylic forms of ginkgolides A, B, and K administered as a ginkgo diterpene lactones meglumine injection in beagle dogs. GA, GB, GDLI
13  2017 [Antagonistic effect of ginkgolide homologues on PAF-induced platelet aggregation and neuroprotective effect]. GA, GB, GC, GJ, GL, GM, PAF
14  2017 [Effects of ginkgolide A, B and K on platelet aggregation]. GA, GB, PAF
15  2017 [Effects of ginkgolide K on platelet aggregation activity and neuroprotection]. I/R, OGD/R, PAF
16  2016 Ginkgolide K protects the heart against endoplasmic reticulum stress injury by activating the inositol-requiring enzyme 1alpha/X box-binding protein-1 pathway. ER, IRE1alpha, XBP1
17  2015 Pharmacokinetic studies of ginkgolide K in rat plasma and tissues after intravenous administration using ultra-high performance liquid chromatography-tandem mass spectrometry. IS, PAF
18  2014 Neuroprotective effect of Ginkgolide K against H2O2-induced PC12 cell cytotoxicity by ameliorating mitochondrial dysfunction and oxidative stress. LDH, MMP, ROS